Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Theravance, Inc.”

369 pharma patents match "Theravance, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 369
Index total 30,257
Page 12 / 16

Quick answer

This filtered view shows 369 pharmaceutical patents matching "Theravance, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

369 results for “Theravance, Inc.” · 30,257 patents in full index Clear search

  1. US 7375181

    Process for purifying glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted May 20, 2008 · Expires May 15, 2028

    granted

  2. US 7375114

    Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted May 20, 2008 · Expires May 15, 2028

    granted

  3. US 7368463

    Substituted 4-amino-1-benzylpiperidine compounds

    Theravance, Inc. · Granted May 6, 2008 · Expires May 1, 2028

    granted

  4. US 7358244

    Azabicycloalkane compounds

    Theravance, Inc. · Granted Apr 15, 2008 · Expires Apr 10, 2028

    granted

  5. US 7355046

    Biphenyl derivatives

    Theravance, Inc. · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted

  6. US 7351704

    Indazole-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Apr 1, 2008 · Expires Mar 27, 2028

    granted

  7. US 7351718

    Substituted pyrrolidine and related compounds

    Theravance, Inc. · Granted Apr 1, 2008 · Expires Mar 27, 2028

    granted

  8. US 7351717

    Substituted pyrrolidine and related compounds

    Theravance, Inc. · Granted Apr 1, 2008 · Expires Mar 27, 2028

    granted

  9. US 7351791

    Intermediate for preparing glycopeptide derivatives

    Theravance, Inc. · Granted Apr 1, 2008 · Expires Mar 27, 2028

    granted

  10. US 7351691

    Glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Apr 1, 2008 · Expires Mar 27, 2028

    granted

  11. US 7345175

    Biphenyl derivatives

    Theravance, Inc. · Granted Mar 18, 2008 · Expires Mar 13, 2028

    granted

  12. US 7345060

    Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Mar 18, 2008 · Expires Mar 13, 2028

    granted

  13. US 7341993

    Cross-linked glycopeptide—cephalosporin antibiotics

    Theravance, Inc. · Granted Mar 11, 2008 · Expires Mar 6, 2028

    granted

  14. US 7332471

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted

  15. US 7329752

    Carbamate compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted

  16. US 7320990

    Crystalline form of a biphenyl compound

    Theravance, Inc. · Granted Jan 22, 2008 · Expires Jan 17, 2028

    granted

  17. US 7317023

    Diaryl ether β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Jan 8, 2008 · Expires Jan 3, 2028

    granted

  18. US 7317022

    Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonists

    Theravance, Inc. · Granted Jan 8, 2008 · Expires Jan 3, 2028

    granted

  19. US 7317102

    Diarylmethyl and related compounds

    Theravance, Inc. · Granted Jan 8, 2008 · Expires Jan 3, 2028

    granted

  20. US 7301004

    Process for preparing glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Nov 27, 2007 · Expires Nov 22, 2027

    granted

  21. US 7288657

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Oct 30, 2007 · Expires Oct 25, 2027

    granted

  22. US 7285564

    Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds

    Theravance, Inc. · Granted Oct 23, 2007 · Expires Oct 18, 2027

    granted

  23. US 7279458

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Oct 9, 2007 · Expires Oct 4, 2027

    granted

  24. US 7265133

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Sep 4, 2007 · Expires Aug 30, 2027

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.